GI
CTSO icon

Gradient Investments’s Cytosorbents Corp CTSO Stock Holding History

Gradient Investments’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-150
Closed -$1K – 1156
2021
Q2 		$1K Sell
150
-1,050
-88% -$8.85K ﹤0.01% 1056
2021
Q1 		$10K Buy
+1,200
New +$11.4K ﹤0.01% 757
2020
Q2 		– Sell
-1,500
Closed -$12K – 1072
2020
Q1 		$12K Buy
+1,500
New +$7.57K ﹤0.01% 610

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gradient Investments's CTSO Position: Q3 2021 in Review

Gradient Investments sold out of Cytosorbents Corp (CTSO) in Q3 2021, closing a stake of 150 shares — an estimated $1K sold.

Gradient Investments first reported a position in CTSO in Q1 2020 and held it in 3 quarters. The position peaked at $12K in Q1 2020. 96 funds tracked by Wall St. Rank hold CTSO as of Q3 2021.

  • Gradient Investments reported no remaining Cytosorbents Corp position as of Q3 2021 after selling out during the quarter.
  • Gradient Investments sold 150 Cytosorbents Corp shares in Q3 2021, an estimated $1K.
  • Gradient Investments first reported a position in Cytosorbents Corp in Q1 2020 and held it in 3 quarters.
  • Gradient Investments's Cytosorbents Corp position peaked at $12K in Q1 2020.
  • 96 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2021.

Based on Gradient Investments's 13F filing for Q3 2021, filed 18 Oct 2021.